Siva Sripada, DO
Interventional Pain Medicine · Flint, MINPI 1174586267
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,216 of the $10,246 with a category attached, or 80.2%. It is spread thinly across 34 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,486, more than ten times the $364 reported in 2019.
Across 271 payments — averaging $37.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$2K
- Boston Scientific$1K
- Medtronic$1K
- Amgen$987
- Globus Medical$769
- Nalu Medical, Inc.$697
- plus $3K from 28 others
What the payments were for
- Travel & lodging$2,03020%
- Food & beverage$8,21680%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 6 | $2,177 |
| Boston Scientific | 18 | $1,316 |
| Medtronic | 17 | $1,250 |
| Amgen | 117 | $987 |
| Globus Medical | 9 | $769 |
| Nalu Medical, Inc. | 19 | $697 |
| Nevro Corp. | 9 | $621 |
| AbbVie | 27 | $325 |
| Abbott | 11 | $297 |
| Stryker | 4 | $251 |
| Averitas Pharma Inc. | 5 | $212 |
| SPR Therapeutics, Inc | 1 | $160 |
| Vertos Medical, Inc. | 1 | $154 |
| Spinal Simplicity, LLC | 1 | $143 |
| MML US, Inc. | 1 | $135 |
| Novo Nordisk | 1 | $124 |
| Curonix LLC | 1 | $123 |
| Neurelis, Inc. | 5 | $98 |
| Brixton Biosciences, Inc. | 1 | $48 |
| Biodelivery Sciences International, Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Octapharma USA, Inc. | 1 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $26 |
| Pfizer | 1 | $26 |
| EMD Serono, Inc. | 1 | $25 |
| Tanabe Pharma America, Inc. | 1 | $25 |
| UCB, Inc. | 1 | $23 |
| Painteq LLC | 1 | $23 |
| Relievant Medsystems, Inc. | 1 | $22 |
| Valinor Pharma, LLC | 1 | $21 |
| Bioventus LLC | 1 | $16 |
| Si-bone, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Hydrocision, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$1,986
- SYNCHROMEDII$726
- Senza$614
- GENERAL PAIN MANAGEMENT$441
- RAYOS$375
- Nalu Neurostimulation System$365
- mild Device Kit$328
- Omnia$233
- SPRINT PNS System$160
- Intracept$149
- HA MINUTEMAN G3-R$143
- ReActiv8$135
- Vyrsa V1$128
- Intracept RF Probe$127
- Wegovy$124
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$123
- Qutenza$121
- PENNSAID$118
- PROCLAIM$109
How this compares
$10,246 in reported general payments places this provider in the 80th percentile of 88 interventional pain medicine providers in Michigan.
See all interventional pain medicine providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 262 | $5,227 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 129 | $2,198 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 138 | $1,827 |
| Pregabalin | 61 | $1,765 |
| Gabapentin | 122 | $1,638 |
| Tizanidine Hcl | 55 | $857 |
| Tramadol Hcl | 107 | $501 |
| Diclofenac Sodium | 20 | $442 |
| Methocarbamol | 37 | $255 |
| Ibuprofen | 24 | $173 |
| Cyclobenzaprine Hcl | 23 | $134 |
| Baclofen | 18 | $134 |
| Meloxicam | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Flint
- Evan PeskinFlint$72K
- Vincent RampersaudFlint$24K
- Ryan PollinaSaint Clair Shores$144K
- Ariel MajjhooMonroe$124K
- Chad BrummettAnn Arbor$109K
- Anand ThakurClinton Township$102K
- Richard FerroLansing$31K
- John ChatasAnn Arbor$29K
- Bryant IttiaraAllen Park$28K
- Fadi DellyWyandotte$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.